These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 19648126)

  • 21. PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease.
    Johansson M; Arlestig L; Hallmans G; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2006; 8(1):R19. PubMed ID: 16507117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.
    Meyer O; Labarre C; Dougados M; Goupille P; Cantagrel A; Dubois A; Nicaise-Roland P; Sibilia J; Combe B
    Ann Rheum Dis; 2003 Feb; 62(2):120-6. PubMed ID: 12525380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
    Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
    J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis.
    Michou L; Teixeira VH; Pierlot C; Lasbleiz S; Bardin T; Dieudé P; Prum B; Cornélis F; Petit-Teixeira E
    Ann Rheum Dis; 2008 Apr; 67(4):466-70. PubMed ID: 17660221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis.
    Rojas-Villarraga A; Diaz FJ; Calvo-Páramo E; Salazar JC; Iglesias-Gamarra A; Mantilla RD; Anaya JM
    J Autoimmun; 2009 Feb; 32(1):64-9. PubMed ID: 19117726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review.
    Luime JJ; Colin EM; Hazes JM; Lubberts E
    Ann Rheum Dis; 2010 Feb; 69(2):337-44. PubMed ID: 19289382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).
    Forslind K; Ahlmén M; Eberhardt K; Hafström I; Svensson B;
    Ann Rheum Dis; 2004 Sep; 63(9):1090-5. PubMed ID: 15308518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
    Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
    Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years.
    Nyhäll-Wåhlin BM; Turesson C; Jacobsson LT; Nilsson JÅ; Forslind K; Albertsson K; Rönnelid J; Petersson IF
    Scand J Rheumatol; 2011 Mar; 40(2):81-7. PubMed ID: 20919947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of valine and leucine at HLA-DRB1 position 11 with radiographic progression in rheumatoid arthritis, independent of the shared epitope alleles but not independent of anti-citrullinated protein antibodies.
    van Steenbergen HW; Raychaudhuri S; Rodríguez-Rodríguez L; Rantapää-Dahlqvist S; Berglin E; Toes RE; Huizinga TW; Fernández-Gutiérrez B; Gregersen PK; van der Helm-van Mil AH
    Arthritis Rheumatol; 2015 Apr; 67(4):877-86. PubMed ID: 25580908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between the PTPN22 1858C->T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study.
    Lie BA; Viken MK; Odegård S; van der Heijde D; Landewé R; Uhlig T; Kvien TK
    Ann Rheum Dis; 2007 Dec; 66(12):1604-9. PubMed ID: 17472988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles.
    Wagner CA; Sokolove J; Lahey LJ; Bengtsson C; Saevarsdottir S; Alfredsson L; Delanoy M; Lindstrom TM; Walker RP; Bromberg R; Chandra PE; Binder SR; Klareskog L; Robinson WH
    Ann Rheum Dis; 2015 Mar; 74(3):579-86. PubMed ID: 24297382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of anti-citrullinated vimentin and anti-citrullinated α-enolase antibodies with subsets of rheumatoid arthritis.
    Montes A; Perez-Pampin E; Calaza M; Gomez-Reino JJ; Gonzalez A
    Arthritis Rheum; 2012 Oct; 64(10):3102-10. PubMed ID: 22674012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation.
    Ytterberg AJ; Joshua V; Reynisdottir G; Tarasova NK; Rutishauser D; Ossipova E; Haj Hensvold A; Eklund A; Sköld CM; Grunewald J; Malmström V; Jakobsson PJ; Rönnelid J; Padyukov L; Zubarev RA; Klareskog L; Catrina AI
    Ann Rheum Dis; 2015 Sep; 74(9):1772-7. PubMed ID: 24817415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
    Dejaco C; Klotz W; Larcher H; Duftner C; Schirmer M; Herold M
    Arthritis Res Ther; 2006; 8(4):R119. PubMed ID: 16859519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
    Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
    Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anti-mutated citrullinated vimentin response classifies patients with rheumatoid arthritis into broad and narrow responders.
    Engelmann R; Brandt J; Eggert M; Karberg K; Krause A; Neeck G; Mueller-Hilke B
    J Rheumatol; 2009 Dec; 36(12):2670-4. PubMed ID: 19884278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis.
    Meyer O; Nicaise-Roland P; Santos MD; Labarre C; Dougados M; Goupille P; Cantagrel A; Sibilia J; Combe B
    Arthritis Res Ther; 2006; 8(2):R40. PubMed ID: 16469118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide.
    Furuya T; Hakoda M; Ichikawa N; Higami K; Nanke Y; Yago T; Kobashigawa T; Tokunaga K; Tsuchiya N; Kamatani N; Kotake S
    Clin Exp Rheumatol; 2007; 25(2):219-24. PubMed ID: 17543145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.